Loading clinical trials...
Loading clinical trials...
Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Rengalin in the Treatment of Cough in Acute Viral Upper Respiratory Tract Infections Tract Infections in Children During the Epidemic Growth of Influenza and ARVI
Conditions
Interventions
Rengalin
Placebo
Locations
30
Russia
Gatchina Clinical Interdistrict Hospital
Gatchina, Russia
Llc "Medlight"
Kazan', Russia
Specialized Clinical Infectious Diseases Hospital
Krasnodar, Russia
Central Research Institute of Epidemiology
Moscow, Russia
First Moscow State Medical University named after I.M. Sechenov
Moscow, Russia
Llc "Diagnosis and Vaccines"
Moscow, Russia
Start Date
October 3, 2025
Primary Completion Date
December 31, 2028
Completion Date
December 31, 2028
Last Updated
February 13, 2026
NCT06504446
NCT05665244
NCT05989698
NCT05273190
NCT07112144
NCT07103980
Lead Sponsor
Materia Medica Holding
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions